Synthetic agonists of Toll-like receptors 7, 8 and 9

S Agrawal, ER Kandimalla - Biochemical Society Transactions, 2007 - portlandpress.com
TLRs (Toll-like receptors) are a family of innate immune receptors that induce protective
immune responses against infections. Single-stranded viral RNA and bacterial DNA …

Immunostimulatory DNA as a vaccine adjuvant

D Higgins, JD Marshall, P Traquina… - Expert review of …, 2007 - Taylor & Francis
Immunostimulatory DNA containing unmethylated CpG motifs is recognized by Toll-like
receptor 9, resulting in the activation of innate immune responses that subsequently amplify …

Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions

JD Marshall, K Fearon, C Abbate… - Journal of Leucocyte …, 2003 - academic.oup.com
Recent reports have identified two major classes of CpG motif-containing
oligodeoxynucleotide immunostimulatory sequences (ISS): uniformly modified …

Triggering of RNA Interference with RNA–RNA, RNA–DNA, and DNA–RNA Nanoparticles

KA Afonin, M Viard, I Kagiampakis, CL Case… - ACS …, 2015 - ACS Publications
Control over cellular delivery of different functionalities and their synchronized activation is a
challenging task. We report several RNA and RNA/DNA-based nanoparticles designed to …

Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists

ER Kandimalla, L Bhagat, Y Li, D Yu… - Proceedings of the …, 2005 - National Acad Sciences
Bacterial DNA and synthetic oligomers containing CpG dinucleotides activate the immune
system through Toll-like receptor (TLR) 9. Here, we compare the immunostimulatory activity …

Chimeric immunomodulatory compounds and methods of using the same—III

KL Fearon, D Dina, SF Tuck - US Patent 7,785,610, 2010 - Google Patents
WEIKWRHPSBSLNX-UHFFFAOYSA-N [5-(2-amino-6-oxo-3H-purin-9-yl)-3-hydroxyoxolan-2-
yl] methyl [5-(4-amino-2-oxopyrimidin-1-yl)-2-(phosphonooxymethyl) oxolan-3-yl] hydrogen …

Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine …

ER Kandimalla, L Bhagat, D Wang, D Yu… - Nucleic Acids …, 2003 - academic.oup.com
Unmethylated CpG dinucleotides present within certain specific sequence contexts in
bacterial and synthetic DNA stimulate innate immune responses and induce cytokine …

'Immunomers'—novel 3′–3′‐linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents

D Yu, ER Kandimalla, L Bhagat, JY Tang… - Nucleic acids …, 2002 - academic.oup.com
Abstract Oligodeoxyribonucleotides containing CpG dinucleotides (CpG DNAs) are currently
being evaluated as novel immunomodulators in clinical trials. Recently, we showed that an …

Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA

RI Mahato, K Cheng, RV Guntaka - Expert opinion on drug delivery, 2005 - Taylor & Francis
Antisense oligodeoxynucleotides, triplex-forming oligodeoxynucleotides and double-
stranded small interfering RNAs have great potential for the treatment of many severe and …

Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics

MA Dobrovolskaia, SE McNeil - Expert opinion on biological …, 2015 - Taylor & Francis
Introduction: Nucleic acid-based therapeutics (NATs) are proven agents in correcting
disorders caused by gene mutations, as treatments against cancer, microbes and viruses …